// App-Quantinova.ai

: Development and Validation of a Population Pharmacokinetic Model for rAHF‐FL‐PEG (Adynovate): A Report on behalf of the WAPPS‐hemo Investigators ad hoc Subgroups

Researchers

Presenter

  • P. Chelle

Principal Investigators

  • C. Yeung

  • S. MacLeod

  • S. Croteau

  • J. Lissick

  • V. Balasa

  • C. Ashburner

  • Y.S. Park

  • S. Bonanad

  • J.E. Megias Vericat

  • A. Iorio

  • A. Edginton

Medical Centers

  • University of Waterloo, School of Pharmacy, Kitchener, Canada

  • Boston Children's Hospital, Boston, United States

  • Children's of Minnesota, Minneapolis, United States

  • Valley Children's Healthcare and Hospital, Madera, United States

  • Kyung Hee University Hospital at Gangdong, Seoul, Korea, Republic of

  • Hospital Universitari I Politecnic La Fe, Valencia, Spain

Locations

  • Canada

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Pharmacokinetics

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A